Innova Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Buy
8,239
+1,126
+16% +$64.7K 0.19% 92
2026
Q1
$431K Buy
7,113
+142
+2% +$8.28K 0.2% 84
2025
Q4
$376K Buy
6,971
+1,460
+26% +$70.2K 0.19% 79
2025
Q3
$249K Buy
5,511
+717
+15% +$33.5K 0.13% 108
2025
Q2
$222K Buy
+4,794
New +$235K 0.13% 97

Other funds holding BMY

Innova Wealth Partners's BMY Position: Q2 2026 in Review

Innova Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, buying an estimated $64.7K and bringing the position to 8,239 shares worth $475K. The position accounts for 0.19% of the portfolio, ranked #92.

Innova Wealth Partners first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. 1,093 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Innova Wealth Partners held 8,239 shares of Bristol-Myers Squibb worth $475K as of Q2 2026.
  • Innova Wealth Partners bought 1,126 Bristol-Myers Squibb shares in Q2 2026, an estimated $64.7K.
  • Bristol-Myers Squibb made up 0.19% of Innova Wealth Partners's portfolio in Q2 2026, its #92 holding.
  • Innova Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
  • 1,093 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Innova Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.